Supportive care for chimeric antigen receptor T-cell (CAR-T) patients.

Deborah SpringellMaeve O'ReillyClaire Roddie

Published in: Current opinion in supportive and palliative care (2023)

For the reasons listed above, standardised, comprehensive supportive care is critically important to ensure that CAR-T therapy is delivered as safely as possible and that patients are fully informed of the risks and benefits, as well as the requirement for extended hospital admission and follow-up, to fully realise the potential of this transformative treatment modality.

Keyphrases

healthcare
end stage renal disease
newly diagnosed
ejection fraction
palliative care
emergency department
prognostic factors
quality improvement
climate change
pain management
electronic health record
smoking cessation